Scholars@Duke publication: Off-target properties of pharmacotherapy and the importance of mechanistic investigations in early clinical phase drug development.

Off-target properties of pharmacotherapy and the importance of mechanistic investigations in early clinical phase drug development.

Publication , Journal Article

Becker, RC

Published in: J Thromb Thrombolysis

April 2007

Published version (DOI) Link to item

Duke Scholars

Author Richard Clinton Becker Medicine, Cardiology

Published In

J Thromb Thrombolysis

DOI

10.1007/s11239-006-0007-3

ISSN

0929-5305

Publication Date

April 2007

Volume

Issue

Start / End Page

159 / 161

Location

Netherlands

Related Subject Headings

Stents
Stem Cells
Quinolines
Infusion Pumps, Implantable
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Humans
Fibrinolytic Agents
Endothelial Cells
Drug-Related Side Effects and Adverse Reactions
Drug Therapy

Citation

APA

Chicago

ICMJE

MLA

NLM

Becker, R. C. (2007). Off-target properties of pharmacotherapy and the importance of mechanistic investigations in early clinical phase drug development. J Thromb Thrombolysis, 23(2), 159–161. https://doi.org/10.1007/s11239-006-0007-3

Becker, Richard C. “Off-target properties of pharmacotherapy and the importance of mechanistic investigations in early clinical phase drug development.” J Thromb Thrombolysis 23, no. 2 (April 2007): 159–61. https://doi.org/10.1007/s11239-006-0007-3.

Becker RC. Off-target properties of pharmacotherapy and the importance of mechanistic investigations in early clinical phase drug development. J Thromb Thrombolysis. 2007 Apr;23(2):159–61.

Becker, Richard C. “Off-target properties of pharmacotherapy and the importance of mechanistic investigations in early clinical phase drug development.” J Thromb Thrombolysis, vol. 23, no. 2, Apr. 2007, pp. 159–61. Pubmed, doi:10.1007/s11239-006-0007-3.

Becker RC. Off-target properties of pharmacotherapy and the importance of mechanistic investigations in early clinical phase drug development. J Thromb Thrombolysis. 2007 Apr;23(2):159–161.

Published In

J Thromb Thrombolysis

DOI

10.1007/s11239-006-0007-3

ISSN

0929-5305

Publication Date

April 2007

Volume

Issue

Start / End Page

159 / 161

Location

Netherlands

Related Subject Headings

Stents
Stem Cells
Quinolines
Infusion Pumps, Implantable
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Humans
Fibrinolytic Agents
Endothelial Cells
Drug-Related Side Effects and Adverse Reactions
Drug Therapy